Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mergers May Buy Time, But Fundamental Change Is Necessary, GSK’s Garnier

Executive Summary

The spate of large scale mergers at the beginning of the decade provided companies with time to deal with patent expirations, but ultimately firms need to fundamentally change their business model, GlaxoSmithKline CEO J.P. Garnier said
Advertisement

Related Content

Roche Re-Models Around Disease Areas, Pulls Together R&D And Commercial
GSK Sees New Round Of “Defensive Mergers” Ahead, CEO Says
GSK Sees New Round Of “Defensive Mergers” Ahead, CEO Says
Advertisement
UsernamePublicRestriction

Register

PS048080

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel